Intracellular targets for nitric oxide toxicity to pancreatic β-cells

Brazilian Journal of Medical and Biological Research

Volumn 29, Issue 5, 1996, Pages 569-579

  Delaney, C A ^a   Eizirik, D L ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

cells; aconitase; DNA damage; insulin dependent diabetes mellitus; nitric oxide; pancreatic islets

Indexed keywords

INTERLEUKIN 1BETA; NITRIC OXIDE;

ANIMAL CELL; CELL DEATH; CELL REGENERATION; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; RAT; REVIEW;

ANIMALS; CELL DEATH; DIABETES MELLITUS, TYPE 1; DNA DAMAGE; HUMANS; ISLETS OF LANGERHANS; MACROPHAGES; NITRIC OXIDE; RATS;

ANIMALIA;

EID: 0029941438     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Castano L & Eisenbarth GS (1991). Type-1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annual Review of Immunology, 8: 647-679.
2. Eizirik DL, Sandler S & Palmer JP (1993). Repair of pancreatic β-cells. A relevant phenomenon in early IDDM? Diabetes, 42: 1383-1391.
3. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Molvig J, Pociot F & Nerup J (1990). Cytokines and free radicals as effector molecules in the destruction of pancreatic β cells. In: Baekkeskov S & Hansen B (Editors), Human Diabetes - Genetic, Environmental and Autoimmune Etiology. Springer, Berlin, Heidelberg, New York, 166-193.
4. Rabinovitch A (1993). Role of cytokines in IDDM pathogenesis and islet β-cell destruction. Diabetes Review, 1: 215-240.
5. Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M & Welsh N (1991). Biochemical and molecular actions of interleukin-1β on pancreatic β-cells. Autoimmunity, 10: 241-253.
6. Corbett JA, Sweetland MA, Wang JL, Lancaster Jr JR & McDaniel ML (1993). Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proceedings of the National Academy of Sciences, USA, 90: 1731-1735.
7. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, Pipeleers DG, Bendtzen K & Hellerström C (1994). Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. Journal of Clinical Investigation, 93: 1968-1974.
8. Griffith OW & Stuher DJ (1995). Nitric oxide syntheses: properties and catalytic mechanism. Annual Review of Physiology, 57: 707-736.
9. Xie Q-W & Nathan C (1994). The high-output nitric oxide pathway: role and regulation. Journal of Leukocyte Biology, 56: 576-582.
10. Gross SS (1995). Nitric oxide: pathophysiological mechanisms. Annual Review of Physiology, 57: 737-769.
11. Southern C, Schulster D & Green IC (1990). Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Letters, 276: 42-44.
12. Eizirik DL & Leijerstam F (1994). The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Diabetes and Metabolism, 20: 116-122.
13. Cunningham JM & Green IC (1994). Cytokines, nitric oxide and insulin secreting cells. Growth Regulation, 4: 173-180.
14. Corbett JA & McDaniel ML (1992). Does nitric oxide mediate autoimmune destruction of β-cells? Diabetes, 41: 897-903.
15. Kolb H & Kolb-Bachofen V (1992). Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia, 35: 796-797.
16. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C & Andersson A (1994). Major species differences between man and rodents in the susceptibility to pancreatic β-cell injury. Proceedings of the National Academy of Sciences, USA, 91: 9253-9256.
17. Welsh N, Eizirik DL & Sandler S (1994). Nitric oxide and pancreatic β-cell destruction in insulin dependent diabetes mellitus: don't take NO for an answer. Autoimmunity, 18: 285-290.
18. Niemann A, Björklund A & Eizirik DL (1994). Studies on the molecular regulation of the inducible form of nitric oxide synthase (NOS) in insulin-producing cells. Molecular and Cellular Endocrinology, 106: 151-155.
19. Bedoya FJ, Flodström M & Eizirik DL (1995). Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA, in insulin producing cells. Biochemical and Biophysical Research Communications, 210: 816-822.
20. Karlsen AE, Andersen HU, Vissing H, Larsen PM, Fey SJ, Cuartero BG, Madsen OD, Petersen JS, Mortensen SB, Mandrup-Poulsen T, Boel E & Nerup J (1995). Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes, 44: 753-758.
21. Eizirik DL, Strandell E, Bendtzen K & Sandler S (1988). Functional characteristics of rat pancreatic islets maintained in culture following exposure to human interleukin-1. Diabetes, 37: 916-919.
22. Rabinovitch A, Clifford P & Baquerizo H (1988). Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinology, 122: 2393-2398.
23. Eizirik DL, Sandler S, Hallberg A, Bendtzen K, Sener A & Malaisse WJ (1989). Differential sensitivity to β-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1β. Endocrinology, 125: 752-759.
24. Malaisse WJ (1992). Glucose-sensing by the pancreatic B-cell: the mitochondrial part. International Journal of Biochemistry, 24: 693-701.
25. Sandler S, Andersson A & Hellerström C (1987). Inhibitory effects of interleukin-1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology, 121: 1424-1431.
26. Eizirik DL (1988). Interleukin-1 induced impairment in pancreatic islet oxidative metabolism is potentiated by tumor necrosis factor. Acta Endocrinologica, 119: 321-325.
27. Borg LAH & Eizirik DL (1990). Short-term exposure of rat pancreatic islets to human interleukin-1β increases cellular uptake of calcium. Immunology Letters, 26: 253-258.
28. Dimmeler S, Ankarcrona M, Nicotera P & Brüne B (1993). Exogenous nitric oxide (NO) generation or IL-1β-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. Journal of Immunology, 150: 2964-2971.
29. Welsh N, Eizirik DL, Bendtzen K & Sandler S (1991). Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology, 129: 3167-3173.
30. Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB & Simmonds RC (1991). Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. American Journal of Physiology, 260: C910-C916.
31. Hausladen A & Fridovich I (1994). Superoxide and peroxynitrite inactivate aconitase, nitric oxide does not. Journal of Biological Chemistry, 269: 29405-29408.
32. Castro L, Rodriquez M & Radi R (1994). Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. Journal of Biological Chemistry, 269: 29409-29415.
33. Eizirik DL, Welsh N, Niemann A, Velloso LA & Malaisse WJ (1994). Succinic acid monomethyl ester protects rat pancreatic islet secretory potential against interleukin-1β (IL-1β) without affecting glutamate decarboxylase expression or nitric oxide production. FEBS Letters, 337: 298-302.
34. Leiter E (1987). Murine macrophages and pancreatic β-cells. Chemotactic properties of insulin and β-cytostatic action of interleukin-1. Journal of Experimental Medicine, 166: 1174-1179.
35. Eizirik DL, Welsh M, Strandell E, Welsh N & Sandler S (1990). Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology, 127: 2290-2297.
36. Welsh N & Sandler S (1992). Interleukin-1β induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets. Biochemical and Biophysical Research Communications, 182: 333-340.
37. Eizirik DL (1991). Interleukin-1β induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity, 10: 107-114.
38. Cetkovic-Cvrlje M & Eizirik DL (1994). TNF-α and IFN-γ potentiate the deleterious effects of IL-1β on mouse pancreatic islets mainly via the generation of nitric oxide, Cytokine, 6: 399-406.
39. Stuehr DJ & Nathan CF (1989). A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. Journal of Experimental Medicine, 169: 1543-1555.
40. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S & Schapira AHV (1994). Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative disease. FEBS Letters, 345: 50-54.
41. Bolaños JP, Peuchen S, Reales SJR, Land JM & Clark JB (1994). Nitric oxide-mediated inhibition of the mitochondnal respiratory chain in cultured astrocytes. Journal of Neurochemistry, 63: 910-916.
42. Krippeit-Drews P, Kröncke K-D, Welker S, Zempel G, Roenfeldt M, Ammon HP, Lang F & Drews G (1995). The effects of nitric oxide on the membrane potential and ionic currents of mouse pancreatic B cells. Endocrinology, 136: 5363-5369.
43. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ & Cohen RA (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature, 368: 850-853.
44. + channel of vascular smooth muscle cells. FEBS Letters, 345: 47-49.
45. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS & Tannenbaum SR (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proceedings of the National Academy of Sciences, USA, 89: 3030-3034.
46. Fehsel K, Jalowy A, Qi S, Burkart V, Hartmann B & Kolb H (1993). Islet DNA is a target of inflammatory attack by nitric oxide. Diabetes, 42: 496-500.
47. Delaney CA, Green MHL, Lowe JE & Green IC (1993). Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the 'comet' assay. FEBS Letters, 333: 291-295.
48. Suarez-Pinzon WL, Strynadka K, Schulz R & Rabinovitch A (1994). Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology, 134: 1006-1010.
49. Delaney CA, Dunger A, Green MHL, Bone AJ & Green IC (1994). DNA damage in neonatal rat islets caused by the combination of tumour necrosis factor-alpha and interferon-gamma. Diabetologia, 37: A44.
50. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR & Bleackley RC (1994). DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia, 37: 733-738.
51. Dunger A, Cunningham JM, Delaney CA, Green MHL, Bone AJ & Green IC (1996). Nitric oxide induced by tumor necrosis factor-alpha and interferon-gamma inhibits insulin secretion and causes DNA damage in neonatal rat islets. Diabetes (in press).
52. Delaney CA, Eizirik DL, Lowe JE, Green MHL, Thorpe JR, Pipeleers DG, Hellerström C & Green IC (1995). Effects of nitric oxide on DNA damage and ultrastructure in islets of Langerhans - a comparison of human and rodent. Diabetologia, 38: A17.
53. Eizirik DL, Delaney CA, Green MHL, Cunningham JM, Thorpe JR, Pipeleers DG, Hellerström C & Green IC (1996). Nitric oxide donors decrease the function and survival of human pancreatic islets. Molecular and Cellular Endocrinology (in press).
54. Cleaver J (1994). It was a good year for DNA repair. Cell, 76: 1-4.
55. de Rojas-Walker T, Tamir S, Ji H, Wishnok JS & Tannenbaum SR (1995). Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chemical Research in Toxicology, 8: 473-477.
56. Sugiura Y & Matsumoto T (1995). Nucleotide-selective cleavage of duplex DNA by nitric oxide. Biochemical and Biophysical Research Communications, 211: 748-753.
57. Victorin K (1994). Review of the genotoxicity of nitrogen oxides. Mutation Research, 317: 43-55.
58. Inoue S & Kawanishi S (1995). Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Letters, 371: 86-88.
59. Hibbs Jr JB, Taintor RR, Vavrin Z & Rachlin EM (1988). Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochemical and Biophysical Research Communications, 157: 87-94.
60. Kwon NS, Stuehr DJ & Nathan CF (1991). Inhibition of tumour cell ribonucleotide reductase by macrophage-derived nitric oxide. Journal of Experimental Medicine, 174: 762-767.
61. Lepoivre M, Flaman JM & Henry Y (1992). Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. Journal of Biological Chemistry, 267: 22994-23000.
62. 6-methylguanine-DNA-methyltransferase. Carcinogenesis, 15: 443-447.
63. Delaney CA, Green MHL, Belgore F & Green IC (1994). The effect of nitric oxide on DNA synthesis and DNA damage in insulin-secreting cells. Diabetic Medicine, 11: A31.
64. Delaney CA (1995). Cytokine and nitric oxide mediated DNA damage and inhibition of function in islets of Langerhans and insulin secreting cell lines. Ph.D. thesis, University of Sussex.
65. Okamoto H (1990). The molecular basis of experimental diabetes. In: Okamoto H (Editor), Molecular Biology of the Islets of Langerhans. Cambridge University Press, Cambridge, 209-231.
66. Radons J, Heller B, Bürkle A, Hartmann B, Rodriguez M-L, Kröncke K-D, Burkart V & Kolb H (1994). Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD depletion. Biochemical and Biophysical Research Communications, 199: 1270-1277.
67. Fernandez-Alvarez J, Tomas C, Casamitjana R & Gomis R (1994). Nuclear response of pancreatic islets to interleukin-1β. Molecular and Cellular Endocrinology, 103: 49-55.
68. Bolaffi JL, Rodd GG, Wang J & Grodsky GM (1994). Interrelationship of changes in islet nicotine adenine dinucleotide, insulin secretion, and cell viability induced by interleukin-1β. Endocrinology, 134: 537-542.
69. Heller B, Wang Z-Q, Wagner EF, Radons J, Bürkle A, Fehsel K, Burkart V & Kolb H (1995). Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. Journal of Biological Chemistry, 270: 11176-11180.
70. Wyllie AH (1992). Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Review, 11: 95-103.
71. Eastman A & Barry MA (1992). The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis. Cancer Investigations, 10: 229-240.
72. Bortner CD, Oldenburg NBE & Cidlowski JA (1995). The role of DNA fragmentation in apoptosis. Trends in Cell Biology, 5: 21-26.
73. 2+ channels exposed to serum from patients with type 1 diabetes. Science, 261: 86-90.
74. Sanchez-Margalet V, Lucas M, Solano F & Goberna R (1993). Sensitivity of insulin-secreting RINm5F cells to undergoing apoptosis by the protein kinase C inhibitor staurosporine. Experimental Cell Research, 209: 160-163.
75. Morgan NG, Cable HC, Newcombe NR & Williams GT (1994). Treatment of cultured pancreatic B-cells with streptozotocin induces cell death by apoptosis. Bioscience Reports, 14: 243-250.
76. Welsh N, Margulis B, Borg LAH, Wiklund HJ, Saldeen J, Flodström M, Mello MA, Andersson A, Pipeleers DG, Hellerström C & Eizirik DL (1995). Differences in the expression of heat shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Molecular Medicine, 1: 806-820.
77. Ankarcrona M, Dypbukt JM, Brüne B & Nicotera P (1994). Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Experimental Cell Research, 213: 172-177.
78. Mitrovic B, Ignarro LJ, Vinters HU, Akers M-A, Schmid I, Uittenbogaarts C & Merrill JE (1995). Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience, 65: 531-539.
79. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T-A, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T & Taniguchi N (1995). Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes, 44: 733-738.
80. Shimaoka M, Iida T, Ohara A, Taenaka N, Mashimo T, Honda T & Yoshiya I (1995). NOC, a nitric oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochemical and Biophysical Research Communications, 209: 519-526.
81. Albina JE, Cui S, Mateo RB & Reichner JS (1993). Nitric oxide-mediated apoptosis in murine peritoneal macrophages. Journal of Immunology, 150: 5080-5085.
82. Meßmer UK, Ankarcrona M, Nicotera P & Brüne B (1994). p53 expression in nitric oxide-induced apoptosis. FEBS Letters, 355: 23-26.
83. Eizirik DL, Sandler S, Ahnström G & Welsh M (1991). Exposure of pancreatic islets to different alkylating agents decreases mitochondrial DNA content but only streptozotocin induces long-lasting functional impairment of β-cells. Biochemical Pharmacology, 42: 2275-2282.
84. Nüssler AK, Geller DA, Sweetland MA, Di Silvio M, Billiar TR, Madariaga JB, Simmons RL & Lancaster Jr JR (1993). Induction of nitric oxide synthesis and its reactions in cultured human and rat hepatocytes stimulated with cytokines plus LPS. Biochemical and Biophysical Research Communications, 194: 826-835.
85. Corbett JA & McDaniel ML (1994). Reversibility of interleukin-1β-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochemical Journal, 299: 719-724.
86. Nunoshiba T, de Rojas-Walker T, Wishnok JS, Tannenbaum SR & Demple B (1993). Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages. Proceedings of the National Academy of Sciences, USA, 90: 9993-9997.
87. Borg LAH, Cagliero E, Sandler S, Welsh N & Eizirik DL (1992). Interleukin-1β increases the activity of superoxide dismutase in rat pancreatic islets. Endocrinology, 130: 2851-2857.
88. Bigdeli N, Niemann A, Sandler S & Eizirik DL (1994). Dissociation between interleukin-1β-induced expression of mRNA for superoxide dismutase and nitric oxide synthase in insulin-producing cells. Biochemical and Biophysical Research Communications, 203: 1542-1547.
89. Eizirik DL, Bjorklund A & Cagliero E (1993). Genotoxic agents increase expression of growth arrest and DNA damage-inducible genes gadd 153 and gadd 45 in rat pancreatic islets. Diabetes, 42: 738-745.
90. Margulis BA, Sandler S, Eizirik DL, Welsh N & Welsh M (1991). Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1β-induced impaired β-cell function. Diabetes, 40: 1418-1422.
91. Bellman K, Wenz A, Radons J, Burkart V, Kleemann R & Kolb H (1995). Heat shock induces resistance in rat pancreatic islets against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. Journal of Clinical Investigations, 95: 2840-2845.